Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening

被引:36
作者
Vrontaki, Eleni [1 ,2 ]
Melagraki, Georgia [1 ]
Mavromoustakos, Thomas [2 ]
Afantitis, Antreas [1 ]
机构
[1] NovaMechanics Ltd, Dept Chemoinformat, Nicosia, Cyprus
[2] Univ Athens, Dept Chem, Organ Chem Lab, GR-10680 Athens, Greece
关键词
3D-QSAR CoMFA; HCV replication inhibitors; molecular docking; PubChem database; virtual screening; HEPATITIS-C VIRUS; DEPENDENT RNA-POLYMERASE; CARBONIC-ANHYDRASE; STRUCTURAL REQUIREMENTS; 3D QSAR; IDENTIFICATION; DERIVATIVES; VALIDATION; DISCOVERY; DESIGN;
D O I
10.3109/14756366.2014.1003925
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A combination of the following computational methods: (i) molecular docking, (ii) 3-D Quantitative Structure Activity Relationship Comparative Molecular Field Analysis (3D-QSAR CoMFA), (iii) similarity search and (iv) virtual screening using PubChem database was applied to identify new anthranilic acid-based inhibitors of hepatitis C virus (HCV) replication. A number of known inhibitors were initially docked into the Thumb Pocket 2 allosteric site of the crystal structure of the enzyme HCV RNA-dependent RNA polymerase (NS5B GT1b). Then, the CoMFA fields were generated through a receptor-based alignment of docking poses to build a validated and stable 3D-QSAR CoMFA model. The proposed model can be first utilized to get insight into the molecular features that promote bioactivity, and then within a virtual screening procedure, it can be used to estimate the activity of novel potential bioactive compounds prior to their synthesis and biological tests.
引用
收藏
页码:38 / 52
页数:15
相关论文
共 80 条
[1]   Development and evaluation of a QSPR model for the prediction of diamagnetic susceptibility [J].
Afantitis, Antreas ;
Melagraki, Georgia ;
Sarimveis, Haralambos ;
Koutentis, Panayiotis A. ;
Markopoulos, John ;
Igglessi-Markopoulou, Olga .
QSAR & COMBINATORIAL SCIENCE, 2008, 27 (04) :432-436
[2]   Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers [J].
Agelis, George ;
Resvani, Amalia ;
Koukoulitsa, Catherine ;
Tumova, Tereza ;
Slaninova, Jirina ;
Kalavrizioti, Dimitra ;
Spyridaki, Katerina ;
Afantitis, Antreas ;
Melagraki, Georgia ;
Siafaka, Athanasia ;
Gkini, Eleni ;
Megariotis, Grigorios ;
Grdadolnik, Simona Golic ;
Papadopoulos, Manthos G. ;
Vlahakos, Demetrios ;
Maragoudakis, Michael ;
Liapakis, George ;
Mavromoustakos, Thomas ;
Matsoukas, John .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :352-370
[3]  
[Anonymous], 2007, SYBYL QSAR COMFA MOL, V2007
[4]  
[Anonymous], 2012, SCHROD SUIT 2012 PRO
[5]  
[Anonymous], 2012, MACROMODEL VERS 9 7
[6]  
[Anonymous], 2012, LIGPREP VERS 2 3
[7]  
Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614
[8]   Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis C [J].
Chang, Mei H. ;
Gordon, Lori A. ;
Fung, Horatio B. .
CLINICAL THERAPEUTICS, 2012, 34 (10) :2021-2038
[9]   Docking-based CoMFA and CoMSIA analyses of tetrahydro-β-carboline derivatives as type-5 phosphodiesterase inhibitors [J].
Cichero, Elena ;
Bruno, Olga ;
Fossa, Paola .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (05) :730-743
[10]   VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD [J].
CLARK, M ;
CRAMER, RD ;
VANOPDENBOSCH, N .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) :982-1012